Clinical Trial Update: Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating SR57667B for progression of symptoms in Parkinson disease has completed. The snippet does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• SR57667B

Snippet

Sponsor: Sanofi | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED